Gastrointestinal effects represent the most common concern: Nausea and vomiting : May be pronounced when initiating either medication or during Wegovy dose escalation Diarrhoea or constipation : Both medications can affect bowel habits Reduced appetite : Wegovy's appetite-suppressing effects combined with SSRI-related nausea may significantly reduce food intake Abdominal discomfort : Bloating, dyspepsia, or gastric pain may occur To minimise gastrointestinal distress, consider taking escitalopram with food and following the gradual Wegovy dose escalation schedule precisely
Inside, you'll get over 100 pages of education, a simple 7-day meal plan with recipes, daily trackers, a lifestyle toolkit, a
Breast cancer is the most common cancer among women, apart from skin cancer, and second only to lung cancer as a leading cause of cancer death in women
Semaglutide has a molecular weight of approximately 4,114 daltons
GLP-1 does stimulate your pancreas to release insulin when glucose (sugar) is present
